In general, the inventive arrangements relate to respiratory care, and more specifically, to improvements in controlling mandatory mechanical ventilation.
Referring generally, when patients are medically unable to breathe on their own, mechanical, or forced, ventilators can sustain life by providing requisite pulmonary gas exchanges on behalf of the patients. Accordingly, modern ventilators usually include electronic and pneumatic control systems that control the pressure, flow rates, and/or volume of gases delivered to, and extracted from, patients needing medical respiratory assistance. Oftentimes, such control systems include a variety of knobs, dials, switches, and the like, for interfacing with treating clinicians, who support the patient's breathing by adjusting the afore-mentioned pressure, flow rates, and/or volume of the patient's pulmonary gas exchanges, particularly as the condition and/or status of the patient changes. Even today, however, such parameter adjustments, although highly desirable, remain challenging to control accurately, particularly using present-day arrangements and practices.
Referring now more specifically, ventilation is a complex process of delivering oxygen to, and removing carbon dioxide from, alveoli within patients' lungs. Thus, whenever a patient is ventilated, that patient becomes part of a complex, interactive system that is expected to promote adequate ventilation and gas exchange on behalf of the patient, eventually leading to the patient's stabilization, recovery, and ultimate ability to return to breathing normally and independently.
Not surprisingly, a wide variety of mechanical ventilators are available today. Most allow their operating clinicians to select and use several modes of ventilation, either individually and/or in various combinations, using various ventilator setting controls.
These mechanical ventilation modes are generally classified into one (1) of two (2) broad categories: a) patient-triggered ventilation, and b) machine-triggered ventilation, the latter of which is also commonly referred to as controlled mechanical ventilation (CMV). In patient-triggered ventilation, the patient determines some or all of the timing of the ventilation parameters, while in CMV, the operating clinician determines all of the timing of the ventilation parameters. Notably, the inventive arrangements described hereinout will be particularly relevant to CMV.
In recent years, mechanical ventilators have become increasingly sophisticated and complex, due, in large part, to recently-enhanced understandings of lung pathophysiology. Technology also continues to play a vital role. For example, many modern ventilators are now microprocessor-based and equipped with sensors that monitor patient pressure, flow rates, and/or volumes of gases, and then drive automated responses in response thereto. As a result, the ability to accurately sense and transduce, combined with computer technology, makes the interaction between clinicians, ventilators, and patients more effective than ever before.
Unfortunately, however, as ventilators become more complicated and offer more options, the number and risk of potentially dangerous clinical decisions increases as well. Thus, clinicians are often faced with expensive, sophisticated machines, yet few follow clear, concise, and/or consistent guidelines for maximal use thereof. As a result, setting, monitoring, and interpreting ventilator parameters can devolve into empirical judgment, leading to less than optimal treatment, even by well-intended practitioners.
Complicating matters ever further, ventilator support should be individually tailored for each patient's existing pathophysiology, rather than deploying a generalized approach for all patients with potentially disparate ventilation needs.
Pragmatically, the overall effectiveness of assisted ventilation will continue to, ultimately depend on mechanical, technical, and physiological factors, with the clinician-ventilator-patient interface invariably continuing to play a key role. Accordingly, technology that demystifies these complex interactions and provides appropriate information to effectively ventilate patients is needed.
In accordance with the foregoing, it remains desirable to provide maximally effective mechanical ventilation parameters, particularly engaging clinicians to supply appropriate quantities and qualities of ventilator support to patients, customized for each individual patient's particular ventilated pathophysiology.
In one embodiment, a method of setting inspiratory time in controlled mechanical ventilation comprises varying a subject's inspiratory times; determining end tidal gas concentrations associated with the inspiratory times; establishing a stable condition of the gas concentrations; and determining an optimal inspiratory time based on a deviation from the stable condition.
In another embodiment, a device for use in controlled mechanical ventilation comprises means for varying a subject's inspiratory times; means for determining end tidal gas concentrations associated with the inspiratory times; means for establishing a stable condition of the gas concentrations; and means for determining an optimal inspiratory time based on a deviation from the stable condition.
A clear conception of the advantages and features constituting inventive arrangements, and of various construction and operational aspects of typical mechanisms provided by such arrangements, are readily apparent by referring to the following illustrative, exemplary, representative, and/or non-limiting figures, which form an integral part of this specification, in which like numerals generally designate the same elements in the several views, and in which:
Referring now to the figures, and in particular to
If desired, the ventilator 16 can also be provided with a bag 28 for manually bagging the patient 12. More specifically, the bag 28 can be filled with breathing gases and manually squeezed by a clinician (not shown) to provide appropriate breathing gases to the patient 12. Using this bag 28, or “bagging the patient,” is often required and/or preferred by the clinicians, as it can enable them to manually and/or immediately control delivery of the breathing gases to the patient 12. Equally important, the clinician can sense conditions in the respiration and/or lungs 30 of the patient 12 according to the feel of the bag 28, and then accommodate for the same. While it can be difficult to accurately obtain this feedback while mechanically ventilating the patient 12 using the ventilator 16, it can also fatigue the clinician if the clinician is forced to bag the patient 12 for too long a period of time. Thus, the ventilator 16 can also provide a toggle 32 for switching and/or alternating between manual and automated ventilation.
In any event, the ventilator 16 can also receive inputs from sensors 34 associated with the patient 12 and/or ventilator 16 at a processing terminal 36 for subsequent processing thereof, and which can be displayed on a monitor 38, which can be provided by the medical system 10 and/or the like. Representative data received from the sensors 34 can include, for example, inspiratory time (TI), expiratory time (TE), natural exhalation time (TEXH), respiratory rates (f), I:E ratios, positive end expiratory pressure (PEEP), fractional inspired oxygen (FIO2), fractional expired oxygen (FEO2), breathing gas flow (F), tidal volumes (VT), temperatures (T), airway pressures (Paw), arterial blood oxygen saturation levels (SaO2), blood pressure information (BP), pulse rates (PR), pulse oximetry levels (SpO2), exhaled CO2 levels (FETCO2), concentration of inspired inhalation anesthetic agent (CI agent), concentration of expired inhalation anesthetic agent (CE agent), arterial blood oxygen partial pressure (PaO2), arterial carbon dioxide partial pressure (PaCO2), and the like.
Referring now more specifically to
Referring now more specifically to
Even more specifically, the various pneumatic elements of the pneumatic circuitry 46 usually comprise a source of pressurized gas (not shown), which can operate through a gas concentration subsystem (not shown) to provide the breathing gases to the lungs 30 of the patient 12. This pneumatic circuitry 46 may provide the breathing gases directly to the lungs 30 of the patient 12, as typical in a chronic and/or critical care application, or it may provide a driving gas to compress a bellows 48 (see
In the embodiment depicted in
Accordingly, the electronic control circuitry 44 of the ventilator 16 can also control displaying numerical and/or graphical information from the breathing circuit 26 on the monitor 38 of the medical system 10 (see
By techniques known in the art, the electronic control circuitry 44 can also coordinate and/or control, among other things, for example, other ventilator setting signals 54, ventilator control signals 56, and/or a processing subsystem 58, such as for receiving and processing signals, such as from the sensors 34, display signals for the monitor 38 and/or the like, alarms 60, and/or an operator interface 62, which can include one or more input devices 64, etc., all as needed and/or desired and interconnected appropriately (e.g., see
Now then, against this background, the inventive arrangements establish ventilation parameters according to patient physiology. These arrangements, to be now described, allow clinicians to control patient ventilation parameters throughout the patient's 12 respiratory cycle and enables ventilation treatments to be individually optimized for patients 12 subject to controlled mechanical ventilation (CMV).
To facilitate the following discussion, the following generalized and/or representative explanations and/or definitions may be referred to:
1. TI is Inspiratory Time.
More specifically, TI is the amount of time, measured in seconds, set on the ventilator 16 by the clinician, lasting from the beginning of the patient's 12 inspiration to the beginning of the patient's 12 expiration. Accordingly, TI is the patient's 12 inspiratory time.
Inspiratory times TI can be further broken down into a set inspiratory time sTI, a delivered inspiratory time dTI, and a measured inspiratory time mTI. More specifically, the set inspiratory time sTI is the amount of time that the clinician sets on the ventilator 16 to deliver gases to the patient 12 during inspiration, while the delivered inspiratory time dTI is the amount of time that gases are actually allowed to be delivered to the patient 12 from the ventilator 16, during inspiration. Similarly, the measured inspiratory time mTI is the amount of time that the ventilator 16 measures for allowing gases to be delivered to the patient 12 during inspiration. Ideally, the set inspiratory time sTI, delivered inspiratory time dTI, and measured inspiratory time mTI are equal or substantially equal. However, if the clinician or ventilator 16 is searching for an optimal inspiratory time TI-OPTIMAL as elaborated upon below, then each of these inspiratory times TI may be different or slightly different. For example, the clinician and/or ventilator 16 may have established a set inspiratory time sTI, yet the delivered inspiratory time dTI may deviate therefrom in the process of searching for, for example, the patient's 12 optimal inspiratory time TI-OPTIMAL.
2. TE is Expiratory Time.
More specifically, TE is the amount of time, measured in seconds, set on the ventilator 16 by the clinician, lasting from the beginning of the patient's 12 expiration to the beginning of the patient's 12 inspiration. Accordingly, TE is the patient's 12 expiratory time.
Like inspiratory times TI, expiratory times TE can also be further broken down into a set expiratory time sTE, a delivered expiratory time dTE, and a measured expiratory time mTE. More specifically, the set expiratory time sTE is the amount of time that the clinician sets on the ventilator 16 to allow the patient 12 to exhale gases during expiration, while the delivered expiratory time dTE is the amount of time that gases are allowed to be exhaled by the patient 12 during expiration. Similarly, the measured expiratory time mTE is the amount of time that the ventilator 16 measures for having allowed the patient 12 to exhale gases during expiration. Ideally, the set expiratory time sTE, delivered expiratory time dTE, and measured expiratory time mTE are equal or substantially equal. However, if the clinician or ventilator 16 is searching for an optimal expiratory time TE, as elaborated upon below, then each of these expiratory times TE may be different or slightly different. For example, the clinician and/or ventilator 16 may have established a set expiratory time sTE, yet the delivered expiratory time dTE may deviate therefrom in the process of searching, for example, for the patient's 12 natural exhalation time TEXH.
3. I:E Ratios are Ratios Between TI and TE.
More specifically, I:E ratios measure inspiratory times divided by expiratory times—i.e., TI/TE, which is commonly expressed as a ratio. Common I:E ratios are 1:2, meaning patients 12 may inhale for a certain period of time (x) and then exhale for twice as long (2x). However, since some patients 12 may have obstructed pathologies (e.g., chronic obstructive pulmonary disease (COPD)) and/or slower exhalation, requiring the clinician to set longer expiratory times TE, I:E ratios can also be set at ratios closer to 1:3 and/or 1:4, particularly to provide the necessary expiratory time TE for a given patient 12 to fully exhale, although I:E ratios from 1:8 and 2:1 are also not uncommon, with common ventilators 16 providing 0.5 gradations therebetween.
4. TEXH is Natural Exhalation Time.
More specifically, TEXH is the amount of time, measured in seconds, required for the patient's 12 natural exhalation flow to cease. Accordingly, TEXH is the patient's 12 natural exhalation time.
Oftentimes, the patient's 12 expiratory time TE does not equal the patient's 12 natural exhalation time TEXH—i.e., the patient's 12 expiratory time TE, as set by the clinician on the ventilator 16, often does not coincide with the patient's 12 natural exhalation time TEXH. Moreover, in accordance with many default settings on many ventilators 16, respiratory rates f (see below) are commonly set between 6-10 breaths/minute and I:E ratios are commonly set at 1:2, resulting in many clinicians setting expiratory times TE between 4.0-6.6 seconds, as opposed to typical natural exhalation times TEXH being less than or equal to approximately 0.8-1.5 seconds. Several of the inventive arrangements, on the other hand, set the patient's 12 expiratory times TE approximately equal to the patient's 12 natural exhalation times TEXH (i.e., 2*TEHX≧TE≧TEXH).
If the clinician or ventilator 16 sets the patient's 12 expiratory time TE less than or equal to the patient's 12 natural exhalation time TEXH, there can be inadequate time for the patient 12 to expel the gases in the patient's 12 lungs 30. This can result in stacking breaths in the patient's 12 lungs 30 (i.e., so-called “breath stacking”), thereby inadvertently and/or unknowingly elevating the patient's 12 lung pressure. Accordingly, several of the inventive arrangements set the patient's 12 expiratory time TE approximately equal to the patient's 12 natural exhalation time TEXH, preferably with the patient's 12 expiratory time TE being set greater than or equal to the patient's 12 natural exhalation time TEXH.
5. PEEP is Positive End Expiratory Pressure.
More specifically, PEEP is the patient's 12 positive end expiratory pressure, often measured in cmH20. Accordingly, PEEP is the amount of pressure in the patient's 12 lungs 30 at the end of the patient's 12 expiratory time TE, as controlled by the ventilator 16.
Like inspiratory times TI and expiratory times TE, positive end expiratory pressure PEEP can also be further broken down into a set positive end expiratory pressure sPEEP, a measured positive end expiratory pressure mPEEP, and a delivered positive end expiratory pressure dPEEP. More specifically, the set positive end expiratory pressure sPEEP is the amount of pressure that the clinician sets on the ventilator 16 for the patient 12, while the measured positive end expiratory pressure mPEEP is the amount of pressure in the patient's 12 lungs 30 at the end of the patient's 12 expiratory time TE. Similarly, the delivered positive end expiratory pressure dPEEP is the amount of pressure delivered by the ventilator to the patient 12. Usually, the set positive end expiratory pressure sPEEP, measured positive end expiratory pressure mPEEP, and delivered positive end expiratory pressure dPEEP are equal or substantially equal. However, the measured positive end expiratory pressure mPEEP can be greater than the set positive end expiratory pressure sPEEP when breath stacking, for example, occurs.
6. FI02 is Fraction of Inspired Oxygen.
More specifically, FI02 is the concentration of oxygen in the patient's 12 inspiratory gas, often expressed as a fraction or percentage. Accordingly, FI02 is the patient's 12 fraction of inspired oxygen.
7. FE02 is Fraction of Expired Oxygen.
More specifically, FE02 is the concentration of oxygen in the patient's 12 expiratory gas, often expressed as a fraction or percentage. Accordingly, FE02 is the patient's 12 fraction of expired oxygen.
8. f is Respiratory Rate.
More specifically, f is the patient's 12 respiratory rate, measured in breaths/minute, set on the ventilator 16 by the clinician.
9. VT is Tidal Volume.
More specifically, VT is the total volume of gases, measured in milliliters, delivered to the patient's 12 lungs 30 during inspiration. Accordingly, VT is the patient's 12 tidal volume.
Like inspiratory times TI and expiratory times TE, tidal volumes VT can also be further broken down into a set tidal volume sVT, a delivered tidal volume dVT, and a measured tidal volume mVT. More specifically, the set tidal volume sVT is the volume of gases that the clinician sets on the ventilator 16 to deliver gases to the patient 12 during inspiration, while the delivered tidal volume dVT is the volume of gases actually delivered to the patient 12 from the ventilator 16 during inspiration. Similarly, the measured tidal volume mVT is the volume of gases that the ventilator 16 measures for having delivered gases to the patient 12 during inspiration. Ideally, the set tidal volume sVT, delivered tidal volume dVT, and measured tidal volume mVT are equal or substantially equal. However, if the clinician or ventilator 16 is searching for a set optimal tidal volume sVT, as elaborated upon below, then each of these set tidal volumes sVT may be different or slightly different.
10. FETCO2 is End Tidal Carbon Dioxide CO2.
More specifically, FETCO2 is the concentration of carbon dioxide CO2 in the patient's 12 exhaled gas, often expressed as a fraction or percentage. Accordingly, FETCO2 is the amount of carbon dioxide CO2 exhaled by the patient 12 at the end of a given breath.
11. VCO2 is the Volume of Carbon Dioxide CO2 per Breath.
More specifically, VCO2 is the volume of carbon dioxide CO2 that the patient 12 exhales in a single breath. Accordingly, VCO2 is the patient's 12 volume of CO2 exhaled per breath.
Now then, clinicians usually begin ventilation by selecting an initial set tidal volume sVT, respiratory rate f, and I:E ratio. The respiratory rate f and I:E ratio usually determine the initial set inspiratory time sTI and initial set expiratory time sTE that the clinician sets on the ventilator 16. In other words, the actual set inspiratory time sTI and actual set expiratory time sTE that the clinician uses are usually determined in accordance with the following equations:
Moreover, the clinician usually makes these initial determinations based on generic rule-of-thumb settings, taking into account factors such as, for example, the patient's 12 age, weight, height, gender, geographical location, etc. Once the clinician makes these initial determinations, the inventive arrangements can now be appreciated.
Referring now to
Referring now to
Thereafter, the patient's 12 natural exhalation time TEXH can be used to set the patient's 12 set expiratory time sTE on the ventilator 16. More specifically, the patient's 12 set expiratory time sTE can be set based on the patient's 12 natural exhalation time TEXH, and, for example, set equal or substantively equal to the patient's 12 natural exhalation time TEXH, as shown in a step 102 in
Now then, in accordance with the foregoing, the patient's 12 set expiratory time sTE is preferably set equal to, or slightly greater than, the patient's 12 natural exhalation time TEXH.
If, however, the patient's 12 natural exhalation flow does not cease at the end of the patient's 12 ventilated set expiratory time sTE, as set by the clinician and/or ventilator, then the clinician can increase the patient's 12 set expiratory time sTE until the patient's 12 natural exhalation flow ceases.
As previously noted, the patient's 12 spontaneous breathing is controlled by numerous reflexes that control the patient's 12 respiratory rates f and tidal volumes VT. Particularly during controlled mechanical ventilation (CMV), however, these reflexes are either obtunded and/or overwhelmed. In fact, one of the only aspects of ventilation that usually remains under the patient's 12 control is the patient's 12 natural exhalation time TEXH, as required for a given volume, as previously elaborated upon. This is why it can be used to set the patient's 12 set expiratory time sTE on the ventilator 16 based thereon.
Now then, the inventive arrangements utilize the patient's 12 natural exhalation time TEXH and/or physiological parameters to determine and/or set the patient's 12 set expiratory time sTE, set inspiratory time sTI, and/or set tidal volume sVT, either directly and/or indirectly. For example, the patient's 12 inspiratory time TI may be set directly, or may it be determined by the respiratory rate f for a specific set expiratory time sTE. Likewise, the patient's 12 set tidal volume sVT may also be set directly, or it may be determined by adjusting the patient's 12 inspiratory pressure (PINSP) in, for example, pressure control ventilation (PCV). Adding the patient's 12 set inspiratory time sTI to the patient's 12 set expiratory time sTE results in a breath time that, when divided from 60 seconds, produces the patient's 12 respiratory rate f. Accordingly, the patient's 12 set inspiration time sTI, set expiration time sTE, and respiratory rate f may not be whole numbers.
Referring now to
Thereafter, the patient's 12 cessation of natural exhalation flow can be used to set the patient's 12 set expiratory time sTE on the ventilator 16. More specifically, the patient's 12 set expiratory time sTE can be set based on the patient's 12 cessation of natural exhalation flow, and, for example, set equal or substantively equal to when the patient's 12 natural exhalation flow ceases, as shown in a step 106 in
Referring now to
Thereafter, the patient's 12 expiration of tidal volume VT can be used to set the patient's 12 set expiratory time sTE on the ventilator 16. More specifically, the patient's 12 set expiratory time sTE can be set based on the patient's 12 expiration of tidal volume VT, and, for example, set equal or substantively equal to when the patient's 12 tidal volume VT expires, as shown in a step 110 in
As previously indicated,
whereby knowing the patient's 12 respiratory rate f and I:E ratio allows determining the patient's 12 set inspiratory time sTI and set expiratory time sTE, while knowing the patient's 12 set inspiratory time sTI and set expiratory time sTE conversely allows determining the patient's 12 respiratory rate f and I:E ratio. Preferably, the clinician and/or the ventilator sets the patient's 12 respiratory rate f and set expiratory time sTE, for which the patient's 12 set inspiratory time sTI and I:E ratio can then be determined using the above equations.
While various mandatory mechanical ventilation modes can be used with the inventive techniques, volume guaranteed pressure control ventilation (i.e., PCV-VG), in particular, will be further described below as a representative example, as it has a decelerating flow profile based on the patient's natural exhalation in response to the ventilator delivered inspiratory pressure, and the set tidal volume sVT is guaranteed by the ventilator on a breath-to-breath basis. However, the inventive arrangements are also equally applicable to other pressure control ventilation (PCV) and/or other ventilator control ventilation (VCV) ventilator modes. In any event, several of the primary control settings on a typical ventilator 16 include controls for one or more of the following: set expiratory time sTE, set inspiratory time sTI, set tidal volumes sVT, and/or fraction of inspired oxygen FIO2.
Now then, according to the patient's 12 physiological measurements in a steady state condition:
In this steady state condition and over a short duration, the patient's 12 blood reservoir is such that VĊO2 is a constant (blood reservoir effects will be elaborated upon below), and, in accordance with this equation, as MVA increases, the patient's 12 end tidal carbon dioxide FETCO2 decreases for a constant VĊO2. Accordingly, substituting MVA=VA*f yields the following:
Accordingly, the same VCO2 can be achieved by increasing the patient's 12 VA and/or decreasing the patient's 12 respiratory rate f. Decreasing the patient's 12 respiratory rate f has the same effect as increasing the patient's 12 delivered inspiratory time dTI on the ventilator 16. In fact, numerous respiratory rate f and delivered inspiratory time dTI combinations can result in equivalent or nearly equivalent VĊO2 production. Accordingly, an optional combination is desired.
As previously described, the patient's 12 natural exhalation time TEXH measures the time period when the patient's 12 natural expiratory gas flow ceases during mechanical ventilation—i.e., the patient's 12 natural exhalation time TEXH comprises the duration of gas flow during the patient's 12 delivered expiratory time dTE. A cessation of flow indicates that the patient's 12 lungs 30 are at their end expiratory lung volume (EELV). Continued gas exchange-beyond EELV could become less efficient, largely as a result of the decreased volume of gases in the patient's 12 lungs 30 leading to reduced gas exchange gradient between the lung and the blood. As a result, initiating a new inspiration (i.e., the patient 12 starts a new breath) can be more efficient.
Referring now to
More specifically, the patient's 12 end tidal carbon dioxide FETCO2 can be considered stable or more stable at or after a point A on a dTI response curve 150 in the figure (e.g., see a first portion 150a of the dTI Response Curve 150) and non-stable or less stable or instable at or before that point A (e.g., see a second portion 150b of the dTI Response Curve 150). Accordingly, the point A on the dTI Response Curve 150 can be used to determine the patient's 12 optimal inspiratory time TI-OPTIMAL, as indicated in the figure.
Physiologically, when the patient's 12 end tidal carbon dioxide FETCO2 is equal to the patient's 12 capillary carbon dioxide FeCO2, diffusion stops and carbon dioxide CO2 extraction from the patient's 12 blood ceases. Ideally, the patient's 12 optimal inspiratory time TI-OPTIMAL is set where this diffusion becomes ineffective or stops. Otherwise, a smaller delivered inspiratory time dTI could suggest that additional carbon dioxide CO2 could be effectively removed from the patient's 12 blood, while a larger delivered inspiratory time dTI could suggest that no additional carbon dioxide CO2 could be effectively removed from the patient's 12 blood.
Preferably, finding the patient's 12 stable end tidal carbon dioxide FETCO2 occurs without interference from the patient's 12 blood chemistry sequelae. A preferred technique for finding the patient's 12 stable end tidal carbon dioxide FETCO2 can increase or decrease the patient's 12 inspiratory time dTI, which may minimally disrupt the patient's 12 blood reservoir of carbon dioxide CO2. Changes in the patient's 12 delivered inspiratory time dTI will affect how the patient's 12 blood buffers the patient's 12 carbon dioxide CO2, and if that blood circulates back to the patient's 12 lungs 30 before the patient's 12 set inspiratory time sTI is optimized, then the patient's 12 end tidal carbon dioxide FETCO2 will be different for a given inspiratory time dTI. At that point, optimizing the patient's 12 set inspiratory time sTI may become a dynamic process. In any event, the time available to find the patient's 12 optimal inspiratory time TI-OPTIMAL may be approximately one (1) minute for an average adult patient 12.
One way to decrease the likelihood 6f interference from the patient's 12 blood chemistry sequelae is to change the patient's 12 delivered inspiratory time dTI for two (2) or more inspirations, and then use the patient's 12 resulting end tidal carbon dioxide FETCO2 to extrapolate using an apriori function, such as an exponential function, by techniques known in the art.
For example, if the patient's 12 first end tidal carbon dioxide FETCO2 was originally determined at a point B on a dTI Response Curve 152 in the figure, and then at a point C, and then at a point D, and then at a point E, and then at a point F, and then at a point G, and then so on, then the data points (e.g., points B-G) could be collected and a best fit dTI Response Curve 152 obtained; extrapolating as needed. Preferably, the dTI Response Curve 152 is piecewise continuous. For example, a first portion 152a of the dTI Response Curve 152 may comprise a stable horizontal or substantially horizontal portion (e.g., points B-D) while a second portion 152b thereof may comprise a polynomial portion (e.g., points E-G). Where this first portion 152a and second portion 152b of the dTI Response Curve 152 intersect (e.g., see point A on the dTI Response Curve 152) can be used to determine the patient's 12 optimal inspiratory time TI-OPTIMAL as indicated in the figure.
For example, referring now to
For example, if the patient's 12 end tidal carbon dioxide FETCO2 was originally determined to be at point C on the dTI response curve 152 (i.e., within the first portion 152a of the dTI response curve 152), then the patient's 12 delivered inspiratory time dTI could be decreased until the patient's 12 next end tidal carbon dioxide FETCO2 was determined to be at point D on the dTI response curve 152, at which point the patient's 12 end tidal carbon dioxide FETCO2 would still be determined to be within the first portion 152a of the dTI response curve 152. Accordingly, the patient's 12 delivered inspiratory time dTI could be decreased again until the patient's 12 next end tidal carbon dioxide FETCO2 was determined to be at point E on the dTI response curve 152, at which point the patient's 12 end tidal carbon dioxide FETCO2 would now be determined to be within the second portion 152b of the dTI response curve 152 (i.e., the patient's 12 end tidal carbon dioxide FETCO2 would have dropped and thus not be at the patient's 12 optimal inspiratory time TI-OPTIMAL). Accordingly, a smaller delivered inspiratory time increment ΔTI/x could be made to determine when the patient's 12 end tidal carbon dioxide FETCO2 was as at point A on the dTI response curve 152—i.e., at the intersection of the first portion 152a of the dTI response curve 152 and the second portion 152b of the dTI response curve 152. In this iterative fashion, successively smaller delivered time increments and/or decrements ΔTI are made to determine the patient's 12 optimal inspiratory time TI-OPTIMAL, as indicated in the figure.
In like fashion, if the patient's 12 end tidal carbon dioxide FETCO2 was originally determined to be at point F on the dTI response curve 152 (i.e., within the second portion 152b of the dTI response curve 152), then the patient's 12 delivered inspiratory time dTI could be increased until the patient's 12 next end tidal carbon dioxide FETCO2 was determined to be at point E on the dTI response curve 152, at which point the patient's 12 end tidal carbon dioxide FETCO2 would still be determined to be within the second portion 152b of the dTI response curve 152. Accordingly, the patient's 12 delivered inspiratory time dTI could be increased again until the patient's 12 next end tidal carbon dioxide FETCO2 was determined to be at point D on the dTI response curve 152, at which point the patient's 12 end tidal carbon dioxide FETCO2 would now be determined to be within the first portion 152a of the dTI response curve 152 (i.e., the patient's 12 end tidal carbon dioxide FETCO2 would not have increased and thus not be at the patient's 12 optimal inspiratory time TI-OPTIMAL). Accordingly, a smaller delivered inspiratory time decrement ΔTI/x could be made to determine when the patient's 12 end tidal carbon dioxide FETCO2 was as at point A on the dTI response curve 152—i.e., at the intersection of the first portion 152a of the dTI response curve 152 and the second portion 152b of the dTI response curve 152. In this iterative fashion, successively smaller delivered time increments and/or decrements ΔTI are again made to determine the patient's 12 optimal inspiratory time TI-OPTIMAL, as indicated in the figure.
In addition, once the patient's 12 optimal inspiratory time TI-OPTIMAL is determined, it is realized this may be dynamic, by which the above arrangements can be repeated, as needed and/or desired.
Now then, a lower bound on the patient's 12 set inspiratory time sTI should be directly related to the minimal time required to deliver the patient's 12 minimal set tidal volume sVT.
A lower bound for the patient's 12 set and delivered tidal volume sVT, dVT should exceed VD, preferably within a predetermined and/or clinician-selected safety margin. Preferably, a re-arrangement of the Enghoff-Bohr equation can be used to find VD or the following variation:
After the patient's 12 end tidal carbon dioxide FETCO2 is determined, then the patient's 12 set tidal volume sVT can be set accordingly, but it may not yet be set at an optimal value. Often, the clinician and/or ventilator 16 will attempt to determine this desired value. For example, the clinician may consider the desired value as the patient's 12 pre-induction end tidal carbon dioxide FETCO2. The clinician can then adjust the patient's 12 set tidal volume sVT until the desired end tidal carbon dioxide FETCO2 is achieved. Alternatively, or in conjunction therewith, a predetermined methodology can also be used to adjust the patient's 12 delivered tidal volume dVT until the desired end tidal carbon dioxide FETCO2 is achieved. For example, such a methodology may use a linear method to achieve a desired end tidal carbon dioxide FETCO2.
Preferably, the clinician can be presented with a dialog box on the monitor 38, for example (see
As previously indicated, different techniques can also be used to search for optimal settings for the ventilator 16. If desired, the delivered values can also be periodically altered to assess whether, for example, the settings are still optimal. Preferably, these alterations can follow one or more of the methodologies outlined above, and they can be determined based on a predetermined and/or clinician-selected time interval, on demand by the physiological, and/or determined by other control parameters, based, for example, on clinical events, such as changes in the patient's 12 end tidal carbon dioxide FETCO2, or on clinical events such as changes in drug dosages, repositioning the patient, surgical events and the like. For example, the patient's 12 delivered inspiratory time dTI can vary about its current value set inspiratory time sTI and the resulting end tidal carbon dioxide FETCO2 can be compared to the current end tidal carbon dioxide FETCO2 to assess the optimality of the current settings. If, for example, a larger delivered inspiratory time dTI leads to a larger end tidal carbon dioxide FETCO2, then the current set inspiratory time sTI could be too small.
In an alternative embodiment, the dTI response curve 154 could be expressed in terms of VCO2 instead of FETCO2, as shown in
One representative summary of potential inputs to, and outputs from, such a methodology is depicted below:
In addition, by more closely aligning the patient's 12 set expiratory time sTE and the patient's 12 natural exhalation time TEXH during mandatory mechanical ventilation, mean alveolar ventilation increases. In addition, there is additional optimal carbon dioxide CO2 removal, improved oxygenation, and/or more anesthesia agent equilibration, whereby ventilated gas exchanges become more efficient with respect to use of lower set tidal volume sVT compared to conventional settings. Minute ventilations and respiratory resistance can be reduced, and reducing volumes can decrease the patient's 12 airway pressure Paw thereby reducing the risk of inadvertently over distending the lung.
In addition, the inventive arrangements facilitate ventilation for patients 12 with acute respiratory distress syndrome, and they can be used to improve usability during both single and double lung ventilations, as well transitions therebetween.
As a result of the foregoing, several of the inventive arrangements set the patient's 12 set expiratory time sTE equal to the time period between when the ventilator 16 permits the patient 12 to exhale and when the patient's 12 expiratory flow ceases—i.e., the patient's 12 natural exhalation time TEXH. This facilitates the patient's 12 breathing by ensuring that ventilated airflows are appropriate for that patient 12 at that time in the treatment. In addition, methods of setting optimal patient inspired time TI-OPTIMAL and desired tidal volume are presented.
It should be readily apparent that this specification describes illustrative, exemplary, representative, and non-limiting embodiments of the inventive arrangements. Accordingly, the scope of the inventive arrangements are not limited to any of these embodiments. Rather, various details and features of the embodiments were disclosed as required. Thus, many changes and modifications—as readily apparent to those skilled in these arts—are within the scope of the inventive arrangements without departing from the spirit hereof, and the inventive arrangements are inclusive thereof. Accordingly, to apprise the public of the scope and spirit of the inventive arrangements, the following claims are made: